Archives
-
Acetylcholine Chloride in Gut-Brain Assays
2026-08-14
Learn how Acetylcholine Chloride can serve as a defined cholinergic stimulus for separating receptor activity, vagal signaling, and microbiota-associated effects. This workflow-focused guide covers fresh-solution preparation, dose-response design, assay controls, and troubleshooting for gut-brain and neuroscience experiments.
-
Calpeptin Workflows for Pulmonary Fibrosis Research
2026-08-14
Calpeptin provides a practical way to perturb calcium-dependent cysteine protease activity while tracking fibrosis, inflammation, and cell-death outcomes in parallel. This guide translates product specifications and cell-death biology into reproducible workflows, assay controls, and troubleshooting strategies for pulmonary fibrosis research.
-
Cepharanthine in Organoid and In Vivo Models
2026-08-13
Cepharanthine connects rapid stromal-cell screening with patient-derived endometrial organoids and an in vivo lesion model. This workflow helps distinguish broad cytotoxicity from cell-cycle arrest, DNA-damage signaling, and mitochondrial apoptosis while providing practical formulation and troubleshooting guidance.
-
Carbon-Ion Radiotherapy, DHODH, and Ferroptosis
2026-08-13
Wang and Cai show that carbon-ion radiotherapy suppresses gastric cancer through a linked mechanism involving DHODH downregulation, ferroptosis, and M1-like macrophage polarization. The study provides a mechanistic framework for examining DHODH as a modifier of carbon-ion treatment response, while its cell-line and xenograft design indicates that clinical translation will require further validation.
-
3-Deazaadenosine in m6A Fibrosis Research
2026-08-12
3-Deazaadenosine offers a metabolic way to test how methylation capacity influences the TTP–WTAP–m6A–TGF-β1 axis identified in schistosomiasis-associated liver fibrosis. This article distinguishes global SAH hydrolase inhibition from pathway-specific m6A experiments and translates that distinction into practical assay design.
-
U0126: MEK1/2 Inhibitor Workflow Guide
2026-08-12
U0126 provides a practical way to test whether MEK1/2–ERK signaling contributes to proliferation, neuronal stress, autophagy, or pain-related phenotypes. This guide connects a defined kinase-inhibition workflow with the ROS–p38–Panx3 mechanism reported in orofacial neuropathic pain, while emphasizing controls, assay timing, and troubleshooting.
-
DiscoveryProbe™ Metabolism-related Compound Library
2026-08-11
The DiscoveryProbe™ Metabolism-related Compound Library provides 493 pre-dissolved compounds for organized screening of metabolic enzymes and pathway regulators when researchers need broad chemical coverage and consistent compound handling. It is intended for controlled in vitro and ex vivo workflows, not for diagnostic, medical, clinical, or unvalidated efficacy claims.
-
JNJ-26481585: HDAC Workflows for Tumor Models
2026-08-11
JNJ-26481585 (Quisinostat) combines potent class I HDAC inhibition with practical readouts for apoptosis, proliferation, and drug resistance. This guide translates TRIM21–ERK1/2 findings into reproducible cell-based workflows and decision points for advancing tumor models.
-
ICAA Targets RIP3 in Cardiac Hypertrophy
2026-08-10
A 2026 Cellular Signalling study identifies isochlorogenic acid A (ICAA) as an inhibitor of RIP3 phosphorylation that reduces angiotensin II- and pressure overload-induced cardiac hypertrophy. Its key mechanistic advance is the discovery that RIP3 promotes hypertrophic remodeling through CaMKII signaling independently of MLKL, separating this activity from canonical necroptosis.
-
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide
2026-08-09
Build more controlled CRISPR-Cas9 genome editing workflows with Cap1-capped, m1Ψ-modified Cas9 mRNA designed for efficient translation and reduced innate immune stimulation. This guide connects RNA preparation, mammalian-cell delivery, specificity testing, and nuclear-export-based assay controls.
-
Netarsudil (AR-13324): A Translational Codelivery Playbook
2026-08-08
Netarsudil (AR-13324) is more than a selective ROCK-pathway probe. Its established effects on actin organization, focal adhesions, trabecular meshwork biology, and aqueous humor outflow intersect with emerging evidence that the molecule can support predictive siRNA nanoparticle codelivery. This thought-leadership analysis connects those findings while separating validated mechanism from translational hypothesis, offering researchers a practical framework for formulation screening, orthogonal phenotyping, and risk-aware progression toward ocular and fibrotic disease models.
-
Macrophage CCL7 and CRC Immunotherapy Resistance
2026-08-07
A 2025 Journal for ImmunoTherapy of Cancer study identifies CCL7-positive tumor-associated macrophages as drivers of colorectal cancer resistance to immune checkpoint blockade. Its data connect macrophage lipid metabolism with reduced CD8+ T-cell infiltration and show that CCL7 inhibition can improve anti-PD-L1 activity in preclinical models.
-
Renalase-Induced Aldosterone Synthesis via PMCA4b/cAMP in Ad
2026-08-07
This study reveals that renalase directly stimulates aldosterone production in NCI-H295R adrenocortical cells by engaging the PMCA4b receptor and activating cAMP/PKA signaling. The findings clarify a non-classical pathway for aldosterone regulation, with potential implications for understanding hyperaldosteronism and its cardiovascular risks.
-
Antipyrine in Translational CNS Research: Model, Metric, and
2026-08-06
This article explores the mechanistic and strategic role of Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) in CNS translational research, with a focus on its validated use as a benchmark for blood-brain barrier (BBB) models, drug metabolism, and pharmacokinetic studies. Integrating new high-throughput permeability assay insights, it provides actionable protocol guidance and a forward-looking perspective for researchers aiming to accelerate CNS drug development.
-
DMG-PEG2000-NH2: Optimizing Liposomal and LNP Drug Delivery
2026-08-06
DMG-PEG2000-NH2 empowers precision bioconjugation in lipid-based drug delivery, excelling as a linker for liposome and LNP systems. This guide details stepwise workflows, troubleshooting strategies, and actionable protocol tips to maximize its benefits for siRNA encapsulation and advanced pharmaceutical research.